Preferences
Related Series
Related Segments


Imaging in the Cloud 2021
Early Adoption Shows Promising Results
Current Time Inside Cache Tag Helper: 6/9/2023 3:29:03 PM and Model.reportId = 1771
Cloud-based technology is quickly gaining momentum among provider organizations, particularly for imaging solutions. To get an early look at the reality of cloud-based imaging and the vendors best positioned to help organizations transition to the cloud, KLAS interviewed 37 organizations that have adopted imaging technology hosted by their vendor in the cloud (i.e., the organizations are leveraging the public or private cloud to operate or store imaging solutions and/or data); of this group, 20 are doing primary PACS production in the cloud. These organizations almost unanimously report positive experiences. Most have successfully transitioned to the cloud and are seeing beneficial outcomes—e.g., decreased IT burden and improved security. Because of the early nature of this market, all vendor performance data is limited (see the About This Report section). This research is also specific to the United States.if you don't have a login, getting started is easy.
Key Findings:
- Fujifilm and INFINITT Lead in Successfully Moving Organizations (Small to Midsize) to Cloud-Based Production Environment
- Philips and IBM Watson Health Make Strides in Cloud Imaging Adoption, with Some Bumps along the Way
- Cloud PACS Production Primarily Done by Smaller Organizations; IBM Watson Health, Sectra Validated for Larger Volumes
- Making the Transition to Imaging in the Cloud

Writer
Amanda Wind Smith

Designer
Madison Moniz

Project Manager
Jill Wilcock
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.